|
|
November 3, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Lewis H. Bender, Founder & CEO,
Intensity Therapeutics |
| In
this Q&A, Bender discusses the insight
behind Intensity's approach, what sets its
delivery platform apart, lessons he's
learned leading a biotech company through
an IPO and late-stage trials, and changes
needed to get more effective, less toxic
treatments to patients faster. More |
|
|
- Accutar: Achievement of Preclinical
Development Milestone in Research
Collaboration With Evommune on TLR7/8 Program
More
- Alfasigma: New Linerixibat Data Across PBC
and Liver Disease to be Presented at AASLD’s
The Liver Meeting 2026 More
- Merck: Initiates Phase 3 Study Evaluating
Ohtuvayre (ensifentrine) for the Prevention of
COPD Exacerbations in Adult Patients Receiving
Standard of Care With a History of
Exacerbations More
- Phathom Pharmaceuticals: Eligible
Commercially Insured Patients May Now Pay as
Little as $0 for VOQUEZNA (vonoprazan) Tablets
Exclusively at BlinkRx More
- SK Life Science: Introduces Access+ to
Simplify the Patient Support Experience
More
- Teva: Will Discontinue Phase 2
TOPAS-MSA Study of Emrusolmin (TEV-‘286)
Following Interim Futility Analysis More
More
More*
|
|
- Amneal: Third Quarter 2026 Financial Results
More
- Biopharma Therapeutics and Platforms R&D
Partnerships – Q3 2026 Review More
- Compass Pathways: Third Quarter 2026
Financial Results and Business Highlights More
- Dianthus Therapeutics: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- Henry Schein: Strong 2026 Third Quarter and
Raises FY2026 Guidance More
- Merck: Recommends Rejection of Tutanota’s
“Mini-Tender” Offer More
- More on FDA Putting Bright Minds
Drug on Partial Hold, Stock Tanking More*
More* More
- More on Regeneron Third-Quarter Revenue
Jumping 36% as Sanofi Collaboration and Eylea
HD Drive Beat More*
More
- Pfizer: Strong Third-Quarter 2026 Results
and Raises 2026 Guidance More
- Syndax: Third Quarter 2026 Financial Results
and Business Update More
|
|
- Big4Bio CEO Weekly Q&A: Lewis H.
Bender, Founder & CEO, Intensity
Therapeutics More
- Biotech & Pharma Updates | November 2,
2026 More
- More on Compass Pointing to Unmet Need in
Depression as Landmark Psychedelic Nears
Market More
- More on FDA Approving Sun Pharma’s Ilumya
for Psoriatic Arthritis, as
Clinic-Administered Il-23 Inhibitor More*
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
| Slone
Partners Places Farhad Ghavami as
Chief Executive Officer at
SeqCenter |
|
Learn More
→ |
|
|
- Anavex Life Sciences: Names Terrie
Kellmeyer, Ph.D., as President and Chief
Executive Officer and Member of the Board of
Directors More
- CollectiveMinds: The Boardroom Is
Changing. Is Your Experience Visible?
More
- OPPORTUNITY: Director of Compliance, Remote
More
- OPPORTUNITY: Head of Market
Development & Strategy, California More
- OPPORTUNITY: Senior Vice President,
Regulatory Affairs & Quality Assurance,
Boston More
- Pfizer: Appoints Cecile Guegan as
Chief Financial Officer More
- Slone Partners: Doing More With Less
- Building the Right Nonprofit Leadership
Team in a Resource-Constrained Environment More
- Slone Partners: Leading Through AI - The New
Playbook for Healthtech Executives More
- Syndax: CFO Transition – Aaron A.
Ondrey Appointed Chief Financial Officer
More
- U.S. Bioscience Jobs Up 7% From 2021 to
2025: Report More
|
|
 |
Events
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- Aggression in Mice: Bridging
Evidence, Best Practices, and Scientific
Rigor
Nov 4
- Scaling Academic Research Programs
Through Strategic Colony Management
Partnerships Nov
11
- 23rd Annual Pantheon Awards
Nov 12
- 2026 LSPA Patient Summit Nov
12
- Patient Pathways (Use code 26B4B10
for 10% off) Nov
17-20
- Pricing & Contracting WEST (Use
code 26B4B10 for 10% off) Dec
7-8
- Trade
and Channel Strategies (Use code 26B4B10
for 10% off) Dec
8-10
- Advancing
Drug Development Forum Dec
10
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|